Pete De Spain | Vice President of Investor Relations |
Troy Wilson | President & Chief Executive Officer |
Marc Grasso | Chief Financial Officer & Chief Business Officer |
Antonio Gualberto | Chief Medical Officer & Head of Development |
Konstantinos Aprilakis | Deutsche Bank |
Tyler Van Buren | Piper Jaffray |
Jonathan Chang | SVB Leerink |
Jay Olson | Oppenheimer |
Joel Beatty | Citi |
Chris Shibutani | Cowen |
Good day, ladies and gentlemen and welcome to the Q2 2019 Kura Oncology Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct the question-and-answer session, and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference is being recorded.